跳至主要内容
临床试验/CTRI/2023/02/049966
CTRI/2023/02/049966招募中4 期

COMPARATIVE STUDY OF IMMUNOGENICITY DEVELOPED FOLLOWING STANDARD AND ACCELERATED HEPATITIS B VACCINATION SCHEDULES

SCHOOL OF TROPICAL MEDICINE0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age more than 18 years and of all genders.
  • Hepatitis B vaccine naïve persons
  • People living with HIV attending out-patient department, ART centre
  • Family members of patients attending hepatitis clinic at school of tropical medicine.

排除标准

  • People with known hepatitis B virus infection.
  • People with chronic kidney disease.
  • People with malignancy or on chemotherapy.
  • People with diagnosed autoimmune disease.
  • People with severe HIV infection (WHO stage 3 and stage 4 disease), with CD4 count less than 200.
  • People on steroids for more than 4 weeks or on any immunomodulator therapy.
  • People received immunoglobulin in last 3 months.
  • People having history of allergy to any vaccine or vaccine compound
  • People with age more than 60 years
  • Patients suffering from any acute illness

研究者

发起方
SCHOOL OF TROPICAL MEDICINE

相似试验

ANTIBODY TITRE DEVELOPMENT FOLLOWING ACCELERATED AND... | 临床试验